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A signature characteristic of Alzheimer’s disease
(AD) is aggregation of amyloid-beta (Ab) fibrils in
the brain. Nevertheless, the links between Ab and
AD pathology remain incompletely understood. It
has been proposed that neurotoxicity arising from
aggregation of the Ab1-42 peptide can in part be ex-
plained by metal ion binding interactions. Using
advanced X-ray microscopy techniques at sub-
micron resolution, we investigated relationships be-
tween iron biochemistry and AD pathology in intact
cortex from an established mouse model over-pro-
ducing Ab. We found a direct correlation of amyloid
plaque morphology with iron, and evidence for the
formation of an iron-amyloid complex. We also
show that iron biomineral deposits in the cortical tis-
sue contain the mineral magnetite, and provide evi-
dence that Ab-induced chemical reduction of iron
could occur in vivo. Our observations point to the
specific role of iron in amyloid deposition and AD pa-
thology, and may impact development of iron-modi-
fying therapeutics for AD.
INTRODUCTION
The accumulation of the peptide fragment amyloid-beta (Ab1-42)
within the brain is a characteristic hallmark of Alzheimer’s dis-
ease (AD) (Selkoe, 1994; Yanker and Lu, 2009). It appears that
the neurotoxicity of Ab is linked to its aggregation state and sub-
sequent involvement in redox cycles (Rival et al., 2009). Further,
studies have suggested that the interaction of metal ions such as
iron and aluminum with Ab, and also copper and zinc, could playCell Chemical Biology 24, 1205–1215, Octo
This is an open access article unda crucial role in the release of reactive oxygen species (ROS) that
contribute to neurodegenerative damage (House et al., 2004;
Khan et al., 2006; Smith et al., 1997). In particular, iron can exist
in both redox-active forms (as ferrous, Fe2+ iron) and redox-inac-
tive forms (as ferric, Fe3+ iron). The aggregation state of Ab1-42
appears to affect the binding of Fe2+ and Fe3+ and thus influ-
ences the iron redox cycle and consequently the release of
free radicals via Fenton chemistry (House et al., 2004; Khan
et al., 2006; Rival et al., 2009). In vitro studies have also demon-
strated that this coexistence of iron and Ab decreases cell
viability, confirming this enhanced toxicity (Liu et al., 2011; Rott-
kamp et al., 2001; Wan et al., 2011).
Evidence for a link between the accumulation of redox-active
iron in the AD brain and the oxidative damage caused by ROS,
has profound implications for understanding the progression
and treatment of the disease. To date, redox-active iron minerals
such as magnetite (Fe3O4) have been found within tissue ex-
tracted from human Alzheimer’s brain (Collingwood et al.,
2005, 2008; Kirschvink et al., 1992), and in brain tissue sections
from APP/PS1 transgenic mice (Gallagher et al., 2012). In addi-
tion, our recent in vitro studies have built on prior work confirming
the formation of redox-active ferrous iron and nanocrystalline
magnetite following the aggregation of Ab with ferric iron in
different forms (Everett et al., 2014a, 2014b). However direct ev-
idence for the in vivo role played by Ab in the iron redox cycle and
the formation of redox-active minerals, remains elusive.
The presence of localized iron in vivo can be detected by MRI
due to its effect on the surrounding tissue, giving rise to detect-
able changes in transverse relaxation (T2) and susceptibility. It is
therefore possible that the presence of iron in AD tissue could be
used as a diagnostic tool (Acosta-Cabronero et al., 2013;
Antharam et al., 2012; Dobson, 2001; El Tannir El Tayara et al.,
2007; Meadowcroft et al., 2009, 2014; Wang et al., 2014).
Crystalline magnetic minerals such as magnetite can strongly
affect MRI contrast. The relative impact of mineralized iron de-
posits on MRI parameters depends very much on the materialsber 19, 2017 ª 2017 The Authors. Published by Elsevier Ltd. 1205
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
properties of the deposits (including crystallinity, iron oxide
phase, and size distribution), and the extent to which the de-
posits are aggregated or disbursed within tissue (Collingwood
and Telling, 2016). It is therefore important to determine which
forms of iron are associated with different pathology in AD, in or-
der to interpret MRI data for the assessment of disease progres-
sion. Further to this, emerging drug treatments based on iron
chelation, such as deferiprone (Devos et al., 2014), are depen-
dent for their efficacy on how strongly the iron is bound in vivo,
i.e., whether molecular or crystal bonding exists, together with
the morphology and surface structure of the iron deposits.
In this study we investigated the oxidation state and distribu-
tion of nanoscale iron in situ in cortical tissue, taken from an
APP/PS1 transgenic mouse model that reproduces the amyloid
deposition characteristic of AD. To probe both iron oxidation and
magnetic state we exploited techniques that use the element-
specific X-ray absorption of soft X-rays (Regan et al., 2001;
van der Laan, 2013; van der Laan and Figueroa, 2014), defined
as having energies between 40 and 2000 eV. Scanning transmis-
sion X-ray microscopy (STXM), which combines spectroscopic
analysis with high-resolution microscopy, has been used in ap-
plications as diverse as catalysis (de Groot et al., 2010), microbi-
ology (Coker et al., 2012; Hunter et al., 2008), and biomaterials
(Leung et al., 2010). In particular, previous studies have used
STXM tomap the oxidation state of iron in different environments
(Coker et al., 2012; Hunter et al., 2008; Tone et al., 2009) an
approach that is also used here.
In addition to the oxidation state, element-specific magnetism
can be detected by measuring the difference in absorption when
using X-rays of either left or right circular polarization (van der
Laan, 2013; van der Laan and Figueroa, 2014). This difference
is known as X-ray magnetic circular dichroism (XMCD) and oc-
curs at specific absorption edges such as the iron L2,3 edges.
The characteristic XMCD spectrum of magnetite (Telling et al.,
2009; van der Laan, 2013; van der Laan and Figueroa, 2014) en-
ables its unambiguous identification, evenwhen crystallographic
information is not available, or when the mineral is combined or
co-located with other non-magnetic iron oxides. Further, XMCD
obtained using STXM provides a powerful combined micro-
scopic probe that can measure oxidation and magnetic state,
and identify different mineral phases on the nanometer scale
(Coker et al., 2012; Hunter et al., 2008). We present the use of
X-ray spectromicroscopy in combination with TEM, to determine
the oxidation state, magnetic state, and morphology of iron de-
posits and their relation to pathological features in AD tissue.
RESULTS AND DISCUSSION
Mapping Protein Structure in Embedded Sections with
X-Ray Spectromicroscopy
Semi-thin adjacent sections of transgenic mouse tissue, taken
from a region encompassing the entorhinal cortex (see Supple-
mental Information; Figure S7) were examined using STXM,
with the X-ray energy tuned to specific absorption features. Pro-
tein (i.e., tissue) maps using the C K-edge p* amide peak (288.2
eV) were obtained of the area surrounding iron deposits prior to
measuring high-magnification iron maps, as shown in Figure 1A.
However, in order to obtain sufficiently thin (<500 nm) specimen
sections for STXMmeasurements it was necessary to embed the1206 Cell Chemical Biology 24, 1205–1215, October 19, 2017tissue in a resin. Most TEM resins contain carbon groups that
produce peaks exactly overlapping the tissue (protein) peaks,
thus destroying contrast in the protein maps.
To avoid this problem we utilized a specialist resin developed
for use in STXM imaging that has been characterized elsewhere
(Li et al., 2009). The effectiveness of this resin is demonstrated in
Figure S1 (Supplemental Information). Characteristic carbon
K-edge X-ray absorption spectra were obtained in a region of
the sample containing mainly tissue, and a region containing
mainly resin (Figure S1A). It can be seen from the figure that
the spectrum from the tissue area contains a significant contribu-
tion from the resin (as expected for embedded tissue) and does
not closely resemble a reference protein C K absorption edge
spectrum (Figure S1C). However by scaling the resin spectrum
to the pre-edge shoulder in the tissue peak and then subtracting
the spectra, it is possible to recover a protein spectrum very
similar to the reference sample (Figures S1B and S1C). In partic-
ular, the post edge peak (labeled * in Figure S1) can be clearly
seen even though this is not easily discernible in the raw spec-
trum from the tissue.
For a given sample it was therefore possible to obtain protein
maps of the tissue by subtracting images obtained at the X-ray
energy corresponding to a strong resin feature (red arrow in Fig-
ure S1A), from those obtained at the p* amide protein peak (blue
arrow in Figure S1A). The resin-subtracted images thus obtained
expose the protein structure (i.e., tissue) in the sections, as
shown for a cortical section of the wild-type mouse tissue sam-
ple in Figures S1D–S1I. As can be seen from this figure, the ob-
tained protein maps reveal detail of the cellular membranes, or-
ganelles, and extracellular matrix, while surface artifacts (such as
the glue contamination seen in Figures S1D and S1E) are
removed.
Analysis of Morphology and Oxidation State of Iron
Following a coarse (low spatial resolution) survey of several adja-
cent sections from both wild-type and transgenic samples, we
examined in detail 15–20 areas of 50 3 50 mm2 for each sample
type where the sections appeared intact, and where these areas
were spaced evenly over a total tissue section area of several
mm2. Areas containing iron deposits were identified by obtaining
iron maps over regions where dense deposits could be dis-
cerned, as demonstrated for a section from the wild-type sample
in Figures S2A–S2C. Using this procedure it was possible to
detect iron deposits down to 100 nm in size within areas
measuring 25 3 25 mm2.
In total, evidence for only four iron oxide deposits was found in
the areas examined in the wild-type tissue sample. One of these
(not shown) was several micrometers in size with straight edges
and was of sufficient thickness to fully absorb X-rays at the Fe L3
absorption edge. This deposit was thus considered to be partic-
ulate surface contamination and was not analyzed further in
this study. The other three iron deposits, shown in Figures
S2D–S2F, appear symmetrical in nature and are approximately
100–300 nm in size. In contrast, we found numerous dense de-
posits in the tissue sections from the transgenic mouse sample.
However due to time constraints it was only possible to probe a
representative proportion of these with the X-ray techniques.
The absence of substantial iron deposits in the wild-type tissue
suggests that the use of 0.1 M sodium cacodylate in the tissue
Figure 1. Spectromicroscopy Analysis of Spatial Distribution, Morphology, and Oxidation State of Iron Deposits within Protein Structure
(A) Protein maps (top) obtained from a cortical section of transgenic mouse tissue showing three areas (A1, A2, and A3) where iron deposits were located.
Corresponding high-magnification iron maps of these deposits are also shown (lower images).
(B) X-ray absorption intensity measured across the Fe L2,3 absorption edge obtained from the iron deposits shown in (A). Also shown in (B) are the absorption
spectra obtained from an Fe3+ reference standard (in this case the iron oxyhydroxide, goethite FeO(OH)), and an Fe2+ reference standard (FeCl2). The strongest
peak intensity was normalized to unity for each spectrum for ease of comparison. The solid line for the spectra from regions A1–A3 corresponds to a best fit using
a superposition of suitably scaled Fe2+ and Fe3+ X-ray absorption spectra (see Figure S3). See also Figures S1 and S2.preparation did not lead to iron accumulation in these samples,
despite prior work which has indicated that sodium cacodylate
(dimethylarsinic acid) can mobilize iron from horse spleen ferritin
in vitro (Ahmad et al., 2000).
All of the deposits from the wild-type tissue displayed Fe L2,3
X-ray absorption spectra identical to that shown in Figure S2G.
Comparison with the reference Fe(III) mineral (goethite) in Fig-
ure S2G indicates that the iron deposits in the wild-type sample
contain predominantly ferric (Fe3+) iron. This is confirmed both by
the correspondence of the peak positions, and the reproduction
of the characteristic shoulder on the low energy side of the main
L3 peak (which is also reflected at the L2 absorption edge).
Although the exact intensity of this shoulder feature is found to
vary for different iron (III) minerals, it is typically approximately
half the height of the main L3 peak.
More extensive tissue damage was seen in the transgenic
mouse sample than in the wild-type sample (Figures 1A and
S1); however, it is not clear if this damage is pathological or
due to tissue fragility during sample preparation. In any case,
high-magnification iron maps of iron deposits in regions, labeled
A1, A2, and A3 in Figure 1A, revealed a clear fine structure to
these deposits. The oxidation state of these iron deposits was
investigated using X-ray absorption spectra obtained from spec-
tromicroscopy measurements (Figure 1B).The oxidation state of iron affects the intensity of the various
X-ray absorption peaks measured at the iron L3 and L2 absorp-
tion edges, as the electron transitions involved are sensitive to
the local electronic structure (van der Laan and Kirkman,
1992). This leads to distinct differences in the shape of the
X-ray absorption spectrum obtained from Fe2+ and Fe3+ ions
(as seen in the case of the reference spectra labeled curves
A andB, respectively, in Figure S3, panel 1). In particular, consid-
ering only the L3 absorption region where the effects can be seen
more clearly, Fe2+ ions show a strong peak at 708 eV and a
broader shoulder at 710 eV, while Fe3+ ions show a strong
peak at 710 eV with a weaker should at 708 eV (indicated
by dashed vertical lines in Figure S3). It is thus possible to distin-
guish these two oxidation states of iron using the L2,3 absorption
spectrum. Further, it is also possible to determine the presence
of Fe2+ ions within a region containing Fe3+ ions, simply by
considering the superposition of the spectra. An illustration of
this is shown in Figure S3 (panel 1) where the reference curves
have been added together in different proportions.
To obtain a more quantitative measure of the percentage
of Fe2+ ions within an iron deposit, i.e., the ratio Fe2+/(Fe2+ +
Fe3+), it was necessary to allow for the different X-ray absorption
cross-sections of the two ion types. This was done by scaling the
measured X-ray absorption spectra for Fe2+ and Fe3+ ions, asCell Chemical Biology 24, 1205–1215, October 19, 2017 1207
Figure 2. Comparison of TEM and STXM Micrographs Showing Correlation of Iron with Amyloid-like Fibril Morphology
(A–C) TEM images from the unstained section measured by STXM in Figure 1, showing fine structure in regions A2 (A) and (B), and A3 (C). The high-magnification
image shown in (B) was obtained from the dotted area shown in (A).
(D–F) Part (D) shows unstained TEM images of fibrillar structures located in a nearby area of the same section. The iron-containing fragment shown in (D) was
observed initially by TEM and subsequently mapped using STXM; iron map shown in (E). A higher-magnification TEM image of the dashed box region in (D) is
shown in (F). See also Figure S3.shown in Figure S3 (panel 2). To determine the percentage of
Fe2+ ions from each X-ray absorption spectrum measured from
the mouse tissue, we performed a non-linear least-squares
fitting procedure using the weighting of the spectra shown in Fig-
ure S3 (panel 2) as fit parameters. From the fits shown in Fig-
ure 1B it can be seen that, while one area (A2) contained predom-
inantly ferric iron, the other areas showed evidence of a
substantial ferrous iron component (nearly 50% Fe2+ for re-
gion A3).
Following STXM examination, high-magnification TEM images
were obtained from areas A2 and A3 (Figure 1A), as shown in Fig-
ure 2. The TEM images in Figures 2A–2C reveal a structure with a
fine fibrousmorphology within the iron deposits. In particular, the
ferrous iron-containing area (A3) shows very fine structure with
an almost amorphous morphology. TEM images from a nearby
area in the same section, not originally examined by STXM, re-
vealed numerous dense fragments with a fibrillar morphology
typical of amyloid plaques obtained from AD tissue (Meadow-
croft et al., 2009), and containing fibrils of between 50 and
150 nm in length (Figures 2D–2F). A subsequent STXM examina-
tion of one of these fragments confirmed a direct correspon-
dence between the iron density (in this case determined by
STXM to be ferric iron) and fibril density from TEM (see Figures
2D and 2E). Image cross-correlation analysis performed on
the images shown in Figures 2D and 2E confirmed a strong
correlation of pixel intensity between the images with a coeffi-
cient, R = 0.91 (20 nm pixel size), suggesting the fibrils them-
selves contained iron as opposed to the presence of discrete1208 Cell Chemical Biology 24, 1205–1215, October 19, 2017iron foci within fibril aggregates. A high-magnification micro-
graph of a thinner area (Figure 2F) revealed fibrils of5 nmwidth
that appear typical of cross-beta-amyloid conformation (Fan-
drich et al., 2011).
Correlation of Iron with Protein Structure
In an adjacent section to that discussed above, some large
dense fragments reminiscent of amyloid plaque deposits were
observed. Combined protein and iron maps covering the area
around these deposits are shown in Figures 3A and 3B. Careful
examination of the protein map in Figure 3A reveals that the iron-
bearing dense fragments shown in Figure 3B also appear in the
protein map andmust thus contain substantial concentrations of
protein or peptide. However, when C K-edge X-ray absorption
spectra were obtained for these regions (Figure 3C), a broad-
ening of the p* amide peak was evident, compared with the
spectrum measured from the surrounding tissue (which is also
identical to the amyloid peptide spectrum [Everett et al.,
2014b]). The presence of iron should not affect the protein
X-ray absorption spectrum directly, as the energy is well below
the Fe L2,3 absorption edge and so X-ray absorption from the
iron should be minimal. We hypothesize that the observed
peak broadening in the protein spectrum may arise from modifi-
cation of the amyloid structure due to the formation of an iron-
amyloid composite.
We were able to exploit this peak broadening to obtain maps
at an alternative energy (labeled P2 in Figure 3C) just below the
p* amide peak (labeled P1). The resulting map using the P2
Figure 3. Spectromicroscopy Analysis of
Co-located Protein and Iron
(A and B) Protein map obtained from unstained
cortical section of transgenic mouse tissue (arrows
show the location of iron-bearing fragments) (A);
false color composite protein (cyan) and iron (red)
map (B) from the region shown in (A).
(C) Carbon K-edge X-ray absorption spectra from
the iron-loaded region (top) and surrounding tissue
(bottom).
(D) Protein map obtained using the alternative
X-ray energy position, P2, shown in (C).
(E) Iron map from the same region as in (D); also
used in the composite image in (B).
(F and G) Iron L2,3 X-ray absorption spectra (F)
obtained from thin areas A4 and A5 shown as
enlarged insets with positions indicated by the
yellow arrows in (G). The solid line for the spectrum
of region A5 corresponds to a best fit using a su-
perposition of suitably scaled Fe2+ and Fe3+ X-ray
absorption spectra (see Figure S3). See also Fig-
ure S4.feature in the broadened protein spectrum is shown in Figure 3D.
Comparison with the iron map in Figure 3E reveals that the ma-
terial displaying the P2 protein spectral feature is exclusively
associated with the iron-rich areas. Although most of this mate-
rial was too dense for spectral analysis of the iron, it was possible
to obtain Fe L2,3 X-ray absorption spectra from two thin regions
in the smaller fragments (Figures 3F and 3G). One of these re-
gions (A5) clearly contained a substantial ferrous (Fe2+) iron
component determined from the fit to constitute 70% of the
iron present (Figure 3F). Further examples of such regions where
iron was found to be co-located with protein structure are shown
in Figure S4. In all these additional regions, a similar broadening
of the p* amide peak was observed wherever iron was co-
located with protein.
In a nearby region on the same section we found a structure
resembling a diffuse amyloid plaque (Dickson and Vickers,
2001) (Figure 4). Using the same methodology outlined above
it was possible to independently map the three following signals
throughout this region: tissue (using the usual P1 spectral peak);
material exhibiting the broadened protein spectrum (using theCell Chemical BioloP2 spectral feature); and iron-containing
material (Figures 4A and 4B). Both the
diffuse plaque and the plaque frag-
ments shown in Figure 3 are consistent
in size and morphology with plaques
imaged previously using immunofluores-
cent techniques from age-matched APP/
PS1 transgenic mice in the same series
as the animal used in the current study
(Gallagher et al., 2012).
From the images in Figures 4A and 4B,
it appears that the iron distribution
exactly matches the plaque morphology.
A detailed mapping of the bottom right
portion of the plaque-like structure using
the weaker Fe L2 absorption edge to
avoid saturation, revealed a near-exactcorrelation between the intensity (i.e., density) of the signal map-
ped using the P2 protein spectral feature (Figure 4D), and that of
the iron (Figure 4E), with an image cross-correlation coefficient of
R = 0.97 (125 nm pixel size). This is consistent with the interpre-
tation that the diffuse plaque is also comprised of a combined
material containing both amyloid and iron, as suggested earlier
for the fibrillar fragments observed by TEM.
In Situ Combined Nanoscale Measurements of Iron
Oxidation and Magnetism
On adjacent semi-thin sections taken from the same transgenic
sample we found particulate iron deposits that showed a strong
spatial variation in iron oxidation state over regions as small as
50 nm, an example of which is shown in Figure 5. Iron L2,3
X-ray absorption spectra taken from representative regions in
the deposit are shown in Figure 5F. For these weaker intensity
spectra, which were obtained with a coarse energy step size, it
was necessary to first convolve the spectra from Figure S3
(panel 2) with a Gaussian function (s = 0.2) prior to fitting. From
the fits shown in Figures 5F and 5A, substantial variation in thegy 24, 1205–1215, October 19, 2017 1209
Figure 4. Spectral Imaging Showing Corre-
lation of Protein with Iron in a Feature
Resembling a Diffuse Amyloid Plaque
(A) False color composite protein map from an
unstained cortical section of the transgenic mouse
tissue. The cyan-colored map was obtained using
the spectral peak labeled P1 in Figure 3C, whereas
the gold-colored map was obtained using the
spectral feature labeled P2 in Figure 3C.
(B) False color composite protein (P1, cyan) and
iron (red) map obtained from the same region as
(A), using the iron L3 absorption peak.
(C–F) Lower images show enlarged high-resolution
proteinmapsmeasured using the spectral features
P1 and P2, (C) and (D); and iron maps using peaks
at the iron L2 and L3 absorption edges (E) and (F),
respectively. The iron map in (F) is saturated and
does not therefore reveal the true iron density
variation that can be seen in (E).Fe oxidation state was determined, ranging from predominantly
ferric iron (region B1), to nearly pure (92%) ferrous iron (re-
gion B4).
It would seem unlikely that such variations are caused by the
coincidental surface contamination of the deposit area by
numerous small (50–200 nm) particles of different oxidation
state iron minerals (Dobson and Grassi, 1996). We also discount
a postmortem oxidation effect caused by variations in the iron
deposit thickness, as themeasured optical density values, which
are directly proportional to the deposit thickness, indicated that
regions B1 and B4 were of approximately the same thickness. In
additional experiments on ferric iron standards we further ruled
out iron reduction caused by either (1) the preparation of semi-
thin sections of material for STXM and TEM analysis, or (2) the
interaction of the X-ray beamwith the sample during STXMmea-
surements. To do this we prepared embedded sections of iron
(III) minerals using identical procedures to those used for the
tissue samples. We also deposited samples of these Fe(III) min-
eral types directly onto electron microscope grids, in order to
assess the potential of the X-ray beam to reduce Fe(III) surface
contaminants.
The X-ray absorption spectra obtained during STXMmeasure-
ments for both of these embedded and surface-exposed sam-
ples are given in Figure S5, and are entirely consistent with ex-
pectations from previously published data (Regan et al., 2001).
The X-ray beam dwell time (exposure time) used for these mea-
surements was increased to three times that used for the tissue
iron deposits, making beam damage (iron reduction) even more
likely in these control experiments. Despite this, no obvious
reduction from a pure Fe3+ valence state was found for either
mineral (Figure S5). Further, the spectra obtained from the
embedded samples were almost identical to those seen for the
surface deposits, ruling out sample preparation as a possible
cause for the iron reduction.1210 Cell Chemical Biology 24, 1205–1215, October 19, 2017The implicit assumption in the previous
fitting analysis is that the Fe2+ and Fe3+
ions originate from different phases
within the iron region being measured;
for example, as would occur when a ferriciron deposit had been partially reduced. However, the presence
ofmixed valence crystallinematerials, such as themagneticmin-
eral magnetite, complicates this simple picture. To detect the
presence of such materials, XMCD was used as this is sensitive
only tomagneticminerals. By remounting the above section onto
a cylindrical permanent magnet and exploiting the circular polar-
ization of the X-ray beam, we were thus able to measure the
magnetic properties of this iron deposit, in situ.
The circular polarization-dependent X-ray absorption spectra
measured under the applied magnetic field are shown in Fig-
ure 6A. The corresponding XMCD spectra obtained by subtract-
ing the spectra for the two polarizations, are shown in Figure 6B.
The X-ray absorption and XMCD spectra obtained from a syn-
thetic magnetite standard sample (labeled M in Figure 6) are
typical for this mineral, with the XMCD spectrum displaying a
characteristic negative-positive-negative peak structure due to
the ordering of magnetic cations (Coker et al., 2012; Telling
et al., 2009; van der Laan, 2013; van der Laan and Figueroa,
2014). The appearance of these features thus indicates the pres-
ence of crystalline and ordered magnetite, while the relative in-
tensity of the different peaks in the XMCD spectrum reveals
the degree of oxidation (i.e., the ratio of Fe2+:Fe3+ cations) of
the mineral.
By examining the spectra from the different regions in the tis-
sue it was possible to elucidate dramatic variations in their oxida-
tion andmagnetic states. The fraction of Fe2+ cations in themag-
netic mineral regions was quantified by fitting calculated XMCD
spectra to the data in Figure 6B (Telling et al., 2009). Assuming
that the magnetite reference sample was stoichiometric with a
corresponding Fe2+/Fe3+ cation ratio of 0.5, it was found that
the three other regions that showed a magnetic (XMCD)
response yielded approximate Fe2+/Fe3+ ratios of 0.7 (B6), 0.4
(B4), and 0.1 (B5). Here, ratios >0.5 indicate reduction, while
those <0.5 indicate oxidation from stoichiometric magnetite.
Figure 5. Spectromicroscopy Identification
of Local Oxidation State Variations in Nano-
scale Particulate Iron
(A) Protein map showing the area surrounding an
iron oxide deposit in a cortical section from the
transgenic mouse sample.
(B–F) Higher-magnification image (B) of the boxed
region in (A), taken at an energy of 350 eV and
showing the iron deposit (dotted red box). Iron
maps recorded using (C) the prominent Fe2+ peak
(708 eV) and (D) the prominent Fe3+ peak (710 eV)
were used for the difference map in (E), which was
obtained by subtracting image (C) from image (D),
and shows localized regions of Fe3+ (bright
contrast) and Fe2+ (dark contrast). The corre-
sponding Fe L2,3 X-ray absorption spectra ob-
tained from the regions labeled B1–B4 are shown
in (F). The solid lines for the spectra B1–B4 corre-
spond to best fit curves using a superposition of
suitably scaled Fe2+ and Fe3+ X-ray absorption
spectra (see Figure S3). See also Figure S5.Taking into account all the spectra in Figures 5F and 6,
together with the above Fe2+/Fe3+ ratios, it was possible to build
a profile of the oxidation state of both magnetic and non-mag-
netic iron phases present in each region of the iron deposit
shown in Figures 5B–5E. From this it appears that, whereas
one region (B1) contained only a non-magnetic Fe3+ phase
consistent with ferrihydrite, regions B4 and B6 both contained
a reduced form of magnetite together with a non-magnetic
Fe2+ iron phase, while region B5 contained a heavily oxidized
form of magnetite (i.e., approaching the maghemite, Fe2O3, stoi-
chiometry). This colocation of different nanoscale iron oxides
provides evidence for a possible redox cycling of the iron.
Several similar particulate iron oxide deposits were found in
adjacent sections that were examined by TEM. In all cases these
deposits were located in electron-dense regions of several
microns in size that were generally non-fibrillar (amorphous) in
nature. A typical example is shown in Figure 7 where an iron
oxidation state map was obtained for the deposit region (Fig-
ure 7C) and compared with the TEM image (Figure 7B). From
these images it can be seen that the most electron-dense area
in the TEM image (Figure 7B) corresponds to an Fe2+-rich region
with an X-ray absorption spectrum (not shown) very similar to re-
gion B4 in Figure 5. Thus, it is possible that the Fe2+ region in Fig-
ure 7 also contains nanoscale magnetite, although we do not
have comparable XMCD measurements to confirm this. Further
examples of regions with a similar morphology and containing
particulate nanoscale iron deposits are presented in Figure S6.
In summary, using a combination of X-ray and electron micro-
scopywe have observed the first direct evidence for iron-bearing
fibrillar aggregates, together with the iron loading of diffuse pla-Cell Chemical Bioloques at the nanoscale level ex vivo. These
results, in addition to the modification
of the peptide spectrum obtained from
the plaques, suggest the composition of
diffuse plaques to be that of an iron-amy-
loid complex. This interpretation supports
previous in vitro studies that suggest a link
between Ab1-42 aggregation and ironaccumulation (Everett et al., 2014a, 2014b; Liu et al., 2011). In
particular the short, disordered fibrils tending to an amorphous
structure, observed here, are remarkably similar to Ab fibrils ob-
tained in vitro where amyloid was allowed to aggregate in the
presence of iron (Everett et al., 2014b; Liu et al., 2011). These
and other in vitro studies suggest that iron could be fundamen-
tally involved in amyloidosis (House et al., 2004; Huang et al.,
2004; Mantyh et al., 1993).
While there are well-documented differences between amy-
loid deposition in the transgenic APP/PS1 mouse model of AD,
and the amyloid deposition observed in human cases of AD,
the observations to date in vitro and in vivo support the hypoth-
esis that there is a fundamental process whereby available iron is
chemically reduced in the presence of aggregating Ab under
physiological conditions. The observations presented here, ob-
tained using advanced synchrotron X-ray microscopy tech-
niques, provide the strongest evidence to date that the iron
chemistry observed in vitro is replicated in vivo in a transgenic
model of Alzheimer’s disease that is directly relevant to the
hypothesis being tested, and these findings are consistent with
observations in material extracted from human brains exhibiting
Alzheimer’s pathology (Collingwood et al., 2008; Plascencia-Villa
et al., 2016).
However, in vivo, it is still not clear whether iron seeds plaque
formation or is integrated at a later stage. In the results presented
here we observed different types of iron-bearing structures;
dense amorphous regions containing localized particulate iron
deposits (including magnetite-based minerals), fibrillar frag-
ments, and diffuse plaque morphology. In the latter two cases
we found a direct nanoscale correlation between protein/fibrilgy 24, 1205–1215, October 19, 2017 1211
Figure 6. In SituMagnetic Characterization of Particulate Iron Using
STXM-XMCD
(A) Fe L2,3 X-ray absorption spectra obtained using X-rays with left circular
polarization (LCP, blue curves) and right circular polarization (RCP, red curves)
for the different regions labeled in Figure 5, together with a reference standard
of magnetite nanoparticles embedded in resin (labeled M).
(B) Corresponding XMCD spectra obtained by subtracting RCP curves from
LCP curves. The positive and negative peaks labeled 1–3 in the magnetite
reference spectrum in (B) are related to: magnetic Fe2+ cations on octahedral
symmetry sites (1); magnetic Fe3+ cations on tetrahedral symmetry sites (2);
and magnetic Fe3+ cations on octahedral symmetry sites (3). The solid red
curves in (B) show an approximate fit of the calculated XMCD spectrum for
each region. All spectra were recorded in a magnetic field of approximately
50 mT applied parallel to the X-ray beam.
Figure 7. TEM and STXM Comparison of Iron Oxidation State and
Structure in Particulate Iron
(A and B) TEM images from an unstained section of cortical tissue from the
transgenic mouse tissue sample. The boxed area in (A) is shown at higher
magnification in (B).
(C) The corresponding Fe2+ and Fe3+ distribution map is shown, where bright
areas correspond to Fe3+-rich regions and dark areas correspond to Fe2+-rich
regions. The labels 1–3 indicate corresponding regions in the TEM image (B)
and iron map (C). See also Figure S6.density and that of iron. This suggests that a seedingmechanism
could be involved for these structures, unless the iron can
permeate the dense plaques after the protein has been depos-
ited. Consequently, iron may play a much greater role in the
development of AD pathology than presently assumed.
Further to this, the observation of substantial levels of ferrous
iron (Fe2+) in the aggregates found in this study, is entirely
consistent with previous in vitro experiments where iron reduc-1212 Cell Chemical Biology 24, 1205–1215, October 19, 2017tion and redox cycling effects were found when Ab1-42 was
incubated in the presence of ferric iron (Fe3+) (Everett et al.,
2014a, 2014b; Huang et al., 1999; Khan et al., 2006). The forma-
tion of redox-active (i.e., ferrous) iron in vivo would provide an
additional free racial burden via Fenton chemistry. Such ferrous
iron would thus contribute further to neurodegeneration via
oxidative stress. Ferrous iron was also found in particulate
iron deposits of 50 nm size. Using X-ray absorption and
XMCD measurements we were able to show crystalline and
ferrimagnetic properties consistent with oxidized and reduced
forms of magnetite. Although nanoscale magnetite has been
found in AD tissue previously (Collingwood et al., 2008; Kirsch-
vink et al., 1992), these results are the first measurements of the
oxidation state of both magnetic and non-magnetic iron in AD
tissue in situ.
As no attempt was made to prevent postmortem oxidation of
tissue in this study, the detection of pure ferrous iron phases sug-
gests other mechanismsmust suppress oxidation. One possibil-
ity is that the iron is preserved in the ferrous state through binding
or coating with amyloid that is in either fibril or amorphous form.
The magnetosome membranes in magnetotactic bacteria are an
example of just such a mechanism, where they have been found
to prevent oxidation of magnetite nanocrystals (Zhu et al., 2015).
Here, the protective effect is consistent with the formation of
an iron-amyloid complex, as discussed earlier. However,
perhaps the most intriguing aspect is the detection of iron with
intermediate oxidation states, providing strong evidence for
redox cycling of iron in vivo. While it has not yet been proven
that the presence of magnetite in the brain is connected to AD
pathology, the formation of the highly reduced iron oxides
observed here is not expected under normal physiological
conditions.
The detection of almost pure Fe2+ oxides is consistent with
previous nanoelectron diffraction studies on pathological ferritin
from AD tissue, where the Fe2+ mineral w€ustite was found to be
the major component of the ferritin core (Quintana et al., 2004).
Further to this, earlier work postulated that the malfunction of
ferritin could act as a precursor to the formation of ferrous
iron-rich minerals (Dobson, 2001). It is possible therefore that
ferritin provides the basis for the iron observed here. Such a
conclusion is also consistent with our previous in vitro experi-
ments where we incubated Ab1-42 with ferrihydrite (the ferric
iron oxyhydroxide core found in physiological ferritin) (Everett
et al., 2014a). In this previous work we found it was possible to
form localized areas containing nanocrystalline magnetite within
amyloid aggregates, due to the reductive effect of the iron-amy-
loid interaction. We also found that the iron was directly corre-
lated with amyloid fibril morphology; a result entirely consistent
with the iron-amyloid association in the tissue samples dis-
cussed here.
There is some evidence in our study to suggest that the oxida-
tion, crystalline, and magnetic state of the iron associated with
plaque material, is linked to the development of the amyloid pa-
thology. For example we found that ferric iron was associated
with diffuse plaques which are historically described as early-
stage pathological structures (Selkoe, 1994), whereas more par-
ticulate and crystalline iron (such as magnetite) was commonly
found within dense amorphous regions resembling plaque cores
in the transgenic APP/PS1 mouse brain tissue presented here,
consistent with prior observations in human Alzheimer’s brain
tissue (Collingwood et al., 2008; Plascencia-Villa et al., 2016).
Given the varying effect of different forms of iron on the relaxation
and susceptibility parameters that determine contrast in MRI
scans, a link between amyloid morphology and iron could serve
as an in vivo diagnostic marker to detect the onset and progres-
sion of the disease, long before substantial pathology has
developed.
Finally, understanding the relationship between iron and the
pathology of AD is vital for the development of treatments using
metal-modifying drugs such as chelators. To date, such treat-
ments have proved among themost successful in demonstrating
benefits in patient trials (Devos et al., 2014). Further to this, a
recent study on APP/PS1 transgenic mice similar to those
used in the work presented here, revealed that the use of the
Fe-chelating drug deferoxamine was able to reduce amyloid pla-
que formation and prevented iron-induced memory impairments
(Guo et al., 2013). Further studies are now required to assess
whether iron loading of amyloid structures is unique to trans-
genic mouse models, or can also be observed in human AD
tissue.
SIGNIFICANCE
We have demonstrated that advanced X-ray microscopy
techniques can be used to map, with nanoscale resolutionand a high degree of chemical specificity, the iron
biochemistry associated with amyloid pathology in a trans-
genic mousemodel of Alzheimer’s disease. The techniques
employed are extremely powerful because of the level of in-
formation that can be obtained without processing the
brain tissue, which here was unstained and chemically un-
fixed. We present the first evidence for iron reduced to a
pure ferrous state that is directly associated with the dense
protein deposits, consistent with amyloid pathology, that
form in the cortex of the APP/PS1 mouse but not the wild-
type. This is completely consistent with the hypothesis
that emerged from prior in vitro experiments, and provides
new evidence that amyloid-induced chemical reduction of
iron could occur in vivo. The combined sensitivity and
specificity of X-ray microscopy has shown that iron
deposits with different morphology and oxidation/mag-
netic states are not merely localized to the regions of pla-
que-like deposition in the APP/PS1 mouse as previously
suggested, but appear to be an integral part of these struc-
tures. Of particular significance, our results indicate that
diffuse amyloid deposits (more typical of early-stage amy-
loid pathology) comprise a bound amyloid-iron composite.
The findings are important both for transgenic models and
for studies of Alzheimer’s disease in humans, to assist with
determining the impact of iron chelation on amyloid depo-
sition, and to optimize contrast-agent-free MRI methods to
evaluate iron-rich amyloid deposits in the brain. Most
importantly, the findings support a model implicating iron
in the actual genesis of amyloid deposition in Alzheimer’s
disease.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Animal maintenance and surgical procedures were performed at Trinity College Institute of Neuroscience, Dublin, Ireland. Specific
pathogen-free (SPF) C57BL/6 mice were purchased from Harlan UK Ltd. (Bicester, UK), whilst transgenic animals from an existing
colony of AbPPswe/PS1dE9 transgenicmicewere purchased from The Jackson Laboratory (Maine, USA), and used to form breeding
pairs with the C57BL/6mice (in an SPF animal housing facility in the Bioresources Unit, Trinity College, Dublin). Mice weremaintained
according to the regulations and guidelines provided by the local ethical committee. All animals were housed under a 12-h light-dark
cycle at an ambient temperature of 22◦C-23C and were maintained under veterinary supervision throughout. Normal laboratory
chow and water were freely available to all animals. Animal experimentation was performed under a license granted by the Minister
for Health and Children (Ireland) under the Cruelty to Animals Act 1876 and the European Community Directive, 86/609/EEC, and
every effort was made to minimize animal stress.
METHOD DETAILS
Preparation of Cortical Tissue Sections
The mouse cortical brain tissue assessed in this study was obtained from two animals: a female mouse aged 8-9 months that was
part of the breeding series from the transgenic AbPPswe/PS1dE9 mice described above and in (Gallagher et al., 2012); and a
14 month old wild-type female mouse. Following anaesthesia, intracardial perfusion was performed for 20 minutes using 0.1M so-
dium cacodylate (Sigma-Aldrich, UK) to prevent metal leaching effects. To avoidmetal contamination the brains were removed using
only ceramic tweezers and forceps, and immediately flash frozen using liquid nitrogen before storing at -80C.
The cortical tissue from the wild-type female mouse was used to develop the methodologies for x-ray spectromicroscopy analysis
for this study, and to confirm that the sample preparation procedures (including the use of 0.1M sodium cacodylate, and ethanol
dehydration prior to resin embedding) did not lead to unusual iron accumulation or the reduction of ferric iron in the final embedded
tissue sections.
The transgenic and wild-type whole brains were transferred in their frozen state to Keele University, where coarse frozen sections
were cut inside the cold chamber of a cryotome, using a sapphire knife. The frozen brain hemisphere was cut into four coarse sec-
tions approximated by the regions shown on the brain map (Mikula et al., 2007) on the RHS of panel 1 in Figure S7 (see Supplementale1 Cell Chemical Biology 24, 1205–1215.e1–e3, October 19, 2017
Information). These coarse sections were defrosted in 0.1 M sodium cacodylate and then dehydrated using an ethanol series. Impor-
tantly, no chemical fixatives or other reagents were added to the sections. This was to prevent any possible metal leaching or
changes in oxidation state of iron within the tissue, although was inevitably to the detriment of the tissue preservation.
Following dehydration the coarse sections were embedded in an aliphatic epoxy resin consisting solely of equimolar amounts of
trimethylolpropane triglycidyl ether and 4,4’-methylenebis-(2-methylcyclohexylamine) (Li et al., 2009), and cured for 2 days at 60C.
This resin is suitable for x-ray spectromicroscopy work due to the lack of strong features in its carbon K-absorption edge spectrum
(Li et al., 2009). Serial semi-thin sections of 200-300 nm were cut from the embedded blocks using glass blades, and deposited onto
either copper TEM grids or silicon nitride membranes. These sections were left unstained for subsequent STXM and TEM investiga-
tions. Further thick sections were also cut for parallel histological investigations (see below) but these were not used for the STXM or
TEM experiments.
In addition to tissue sections, embedded sections of iron oxide mineral standards were obtained using identical procedures by
dispersing the oxides in agar to form gels, and subsequently exposing these gels to 0.1 M sodium cacodylate for 10 mins before
dehydrating them using an ethanol series. These samples were then resin embedded and sectioned as described above.
Histological Staining
Following resin embedding of the transgenic mouse brain tissue, thick sections ( 1 mm) were cut and mounted on glass slides and
stained with toluidine blue dye (LHS, Figure S7). Congo red staining of resin-embedded sections from region 1 was also performed
using the protocol by Shirahama (Shirahama and Cohen, 1966). The Congo red stained sections were examined for birefringence
under cross-polarized light using an Olympus IX51 microscope. Numerous areas containing structures of 1 mm size that displayed
‘‘apple-green’’ birefringence characteristic of fibrillar amyloid, were found throughout region 1 (a typical example is shown in Panel 2,
Figure S7 in Supplemental Information). The semi-thin sections (200-300nm) cut from region 1 were left unstained and mounted on
copper grids and silicon nitride membranes for further study.
Synchrotron X-Ray Spectromicroscopy
X-ray spectromicroscopy experiments were performed with circularly polarised light on the 10ID1 beamline at the Canadian Light
Source, using the scanning transmission x-ray microscopy (STXM) endstation. Microscopy images were acquired by tuning the inci-
dent beam to a specific x-ray energy, and raster scanning across the area of interest (the x-ray spot size was 30 nm) with sample
exposure times <2 ms per pixel for each image in order to prevent radiation damage.
To obtainmaps corresponding to particular elements or oxidation states, paired imageswere acquired at the desired x-ray absorp-
tion feature and at a corresponding energy several eV from the feature, and subtracted from each other. This procedure ensures that
only structure containing the spectral feature of interest will appear in the map. For example, an iron map obtained using an image
recorded at the 710 eV peak and an off-peak background image at 705 eV, will show only structure containing iron and all other struc-
ture will be removed from the image.
Spectromicroscopy was performed by recording a series of images at different x-ray energies across the same area with an expo-
sure time of 2 ms per pixel. The image series was converted to optical density (OD) by recording the incident x-ray flux in a nearby
region not containing the sample (for e.g. a hole in the resin). Regions of interest could then be defined within the image series in order
to obtain the corresponding spectra.
XMCDmeasurements were obtained by mounting a silicon nitride membrane containing a tissue section, onto a hollow cylindrical
permanent magnet in order to pass the x-ray beam. A reference sample containing synthetic magnetite nanopowder (Sigma-Aldrich,
UK) embedded in resin using the identical procedure as for the tissue sample, was mounted on an identical magnet alongside the
tissue section. The reference sample was prepared several months after the tissue sections and so no cross sample contamination
was possible. As mounted, the magnetic field at the central position of each sample was 50 mT, which was sufficient to partially
magnetise the magnetite nanoparticles. XMCD was obtained by recording an image series across the iron L3 absorption edge
with both left and right circularly polarised x-rays, using an exposure time of 4 ms per pixel.
The two magnets were mounted in an opposing field configuration such that any XMCD signal in the tissue sample should be in-
verted with respect to the magnetite reference sample, providing additional validation of any apparent XMCD (i.e. magnetic) signal in
the tissue. During data analysis the raw data from the magnetite reference sample were subsequently inverted to facilitate compar-
ison with spectra obtained from the tissue sample.
STXM data and image processing were performed using the aXis2000 software package (http://unicorn.mcmaster.ca/aXis2000.
html). For iron L2,3 x-ray absorption spectra and XMCD, a 3-point smoothing filter was applied to the raw data. The brightness and
contrast levels of raw images were adjusted, and composite maps were obtained by converting grey scale images to false colour and
then recombining the images as overlays using the ImageJ software package.
Transmission Electron Microscopy
TEM was performed on unstained semi-thin sections using a JEOL 1230 instrument operating at 100 kV. Unless specified other-
wise, TEM measurements were conducted on sections after the completion of STXM measurements on the same sections, in or-
der to avoid electron beam damage. However due to the fragility of the sections it was not possible to subject all of them to both
STXM and TEM analysis. In the one case where a section previously examined by TEM was subsequently measured by STXM, it
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obtained. However iron mapping, which uses much stronger spectral features and is thus less sensitive to electron beam damage,
was still possible on this section.
QUANTIFICATION AND STATISTICAL ANALYSIS
Fits to x-ray absorption data were obtained using a non-linear least squares fitting procedure. Image cross correlation analysis was
performed using the ImageJ plugin called ImageCorrelationJ.
DATA AND SOFTWARE AVAILABILITY
Raw and analysed data: http://dx.doi.org/10.21252/keele-0000012e3 Cell Chemical Biology 24, 1205–1215.e1–e3, October 19, 2017
